ProCE Banner Activity

Phase I/II CHAMPION-1: Weekly Carfilzomib/Dexamethasone for Relapsed/Refractory Myeloma

Slideset Download
Conference Coverage
Weekly carfilzomib/dexamethasone is active with similar or lower toxicity than historical data with standard twice-weekly dosing.

Released: December 09, 2015

Expiration: December 07, 2016

No longer available for credit.

Share

Provided by

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ProCE Banner

Supporters

Amgen, Inc.

Celgene

Incyte

Merck & Co., Inc.

Millennium Takeda

Seagen